Fill & finish of vials, pre-filled syringes and cartridges deploying single-use technology
Polpharma Biologics method development, qualification and validation for late stage development define the robust control strategy required to manufacture and commercialize biologic molecules.
We run multiparametric experiments in parallel using ambr® high-throughput systems to optimize media and culture conditions for scalability. Required USP process characterization is performed based on qualified scale-down models and is supported by high-throughput analytical instrumentation.
Aggregation and particle characterization:
HIAC for pharmacopoeial measurements
MFI for particles counting and imaging
Nephelometer for turbidity measurement
DLS and SEC-UPLC for aggregation determination
Other capabilities:
Rheometer and mVROC for rheological properties determination
Visual inspection station
Container closure integrity determination by dye ingress test
Stability chambers
Working with our fill finish team
“We are committed to positive outcomes and delivering projects on time to specification”
We can support any projects fill finish requirements and utilize our know-how, state-of-the-art equipment and proprietary technologies to deliver. We understand that we are delivering products for clinical and commercial supply and we always endeavor to get your product to patients, on time.
Warning against fraudulent internet recruitment activities:
Our attention has been drawn to the fraudulent activities of persons posing as recruitment agencies or Polpharma Biologics employees. The fraud involves sending people a request for personal information, making job offers and/or extorting fees for recruitment-related accommodation or preparation sessions ahead of an interview or assessment centre. We would like to make it clear that Polpharma Biologics never requires candidates to make payment during a recruitment process.
Read more here.
PL
EN
